Skip to content
  • The Bactiguard Technology
  • License Partnerships
  • Wound Management
  • Investors

Blog category

April 16, 2021

Bactiguard proud founder and member of Vision Zero initiative for India
Healthcare associated infections, Updates16 April 2021

BACTIGUARD AB

Vasagatan 11, 111 20 Stockholm Alfred Nobels Allé 150, 146 48 Tullinge PO Box 15, 146 21 Tullinge, Sweden +46 8 440 58 80 info@bactiguard.com

About Bactiguard

  • Contact
  • About us
  • History
  • Purpose, vision and mission
  • Education
  • Whistleblower

Our business

  • License Partnerships
  • The Bactiguard Technology
  • Clinical evidence
  • Healthcare challenges
  • Education
  • Updates
  • Investors

©2025 Bactiguard AB. All Rights Reserved.

Privacy policy
Cookies
Youtube
LinkedIn
Go to Top
Search
  • License Partnerships
    • Strategic therapeutic areas
  • The Bactiguard Technology
    • Medical devices
      • Implants
        • ZNN™ Bactiguard
      • Intensive care
        • BIP Central Venous Catheter
        • BIP Endotracheal Tube
        • BIP Endotracheal Tube Evac
        • BIP Foley TempSensor
      • Urology
        • BIP Foley Catheter
        • BIP Foley Catheter – Silicone
        • Education
          • Catheter treatment
            • Who needs catheter treatment?
            • Catheter treatment types
            • Which catheter to choose
            • How to catheterize?
            • Documentation
            • Patient care (catheter care)
            • Common complications
            • Definitions
  • Wound Management
    • Hydrocyn Aqua
      • Test results
    • Surgical sutures
    • Menu iconDistributor login
  • Healthcare challenges
    • Antimicrobial resistance (AMR)
    • Biofilm
    • HAI/Medical device related infections
      • Catheter associated urinary tract infection
      • Catheter related bloodstream infection
      • Ventilator associated pneumonia
    • Sepsis
  • Clinical evidence
  • About us
    • Purpose, vision and mission
    • Business model
    • History
  • Media
    • Press releases
    • Updates
  • Contact
    • Head office
    • Whistleblower
  • Menu iconInvestors
Get more information